Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Yahoo Finance Nawigacja wpisu Press Release: Sanofi to acquire Blueprint Medicines, – GlobeNewswire Sanofi to buy Blueprint Medicines in deal worth more than $9 billion – statnews.com
